³í¹®) Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real‐world experience °¡Å縯´ë ¿©Àǵµ¼º¸ðº´¿ø ¸²ÇÁÁ¾¼¾ÅÍ Á¶¼®±¸·Àü¿µ¿ì ±³¼ö ¿¬±¸ÆÀ